RxDoctor Payments Data

Jennifer Rocha, PA

Physician Assistant · San Luis Obispo, CANPI 1821343757

Payments from drug & device makers

$1,094in general payments, 2019–2025

Across 56 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$236
  • AstraZeneca$180
  • Lilly USA, LLC$159
  • Boehringer Ingelheim$143
  • Exact Sciences$79
  • Novo Nordisk$61
  • plus $236 from 8 others

What the payments were for

  • Food & beverage$1,094100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,094 in reported general payments places this provider in the 70th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$129,686
Medicare patients
442
Services billed
1,467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$57,525
XareltoRivaroxaban23$24,794
OzempicSemaglutide27$23,613
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$18,091
BelsomraSuvorexant34$17,450
MounjaroTirzepatide15$15,685
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$8,137
Testosterone21$2,784
Lidocaine11$1,971
Eszopiclone13$1,766
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen77$1,504
Atorvastatin Calcium135$1,466
Gabapentin79$1,289
Levothyroxine Sodium96$1,211
Albuterol Sulfate HfaAlbuterol Sulfate29$1,099

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$26$57,52556 claims
GSKTrelegy Ellipta, Anoro Ellipta$236$26,22842 claims
Novo NordiskOzempic$61$23,61327 claims
Lilly USA, LLCMounjaro$159$15,68515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,423 physician assistant providers in California.

Other physician assistant in San Luis Obispo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →